Genome-wide RNAi Screen Reveals a New Role of a WNT/CTNNB1 Signaling Pathway as Negative Regulator of Virus-induced Innate Immune Responses

PLoS Pathogens

Volumn 9, Issue 6, 2013, Pages

  Baril, Martin ^a   Es Saad, Salwa ^a   Chatel Chaix, Laurent ^a   Fink, Karin ^b   Pham, Tram ^c   Raymond, Valérie Ann ^b   Audette, Karine ^a   Guenier, Anne Sophie ^a   Duchaine, Jean ^a   Servant, Marc ^d   Bilodeau, Marc ^b,d   Cohen, Éric ^c   Grandvaux, Nathalie ^b,d   Lamarre, Daniel ^a,b,d  

^a INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

^c CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; GLYCOGEN SYNTHASE KINASE 3 INHIBITOR; RETINOIC ACID INDUCIBLE PROTEIN I; SHORT HAIRPIN RNA; WNT PROTEIN; WNT2 PROTEIN; WNT9B PROTEIN;

ARTICLE; BIOINFORMATICS; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPRESSION VECTOR; GENE SILENCING; GENETIC ASSOCIATION; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; INNATE IMMUNITY; LUMINESCENCE; MICROARRAY ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SENDAI VIRUS INFECTION; WESTERN BLOTTING;

CARRIER PROTEINS; CELL LINE; DEAD-BOX RNA HELICASES; FEMALE; GENE EXPRESSION REGULATION; GENOME-WIDE ASSOCIATION STUDY; GLYCOPROTEINS; HUMANS; IMMUNITY, INNATE; INTERFERON-BETA; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; RESPIROVIRUS INFECTIONS; RNA INTERFERENCE; SENDAI VIRUS; WNT PROTEINS; WNT SIGNALING PATHWAY;

SENDAI VIRUS;

EID: 84879539109     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003416     Document Type: Article

References (75)

1. Yoneyama M, Kikuchi M, Matsumoto K, Imaizumi T, Miyagishi M, et al. (2005) Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J Immunol 175: 2851-2858.
2. Seth RB, Sun L, Ea CK, Chen ZJ, (2005) Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122: 669-682.
3. Meylan E, Curran J, Hofmann K, Moradpour D, Binder M, et al. (2005) Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437: 1167-1172.
4. Xu LG, Wang YY, Han KJ, Li LY, Zhai Z, et al. (2005) VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol Cell 19: 727-740.
5. Kawai T, Takahashi K, Sato S, Coban C, Kumar H, et al. (2005) IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol 6: 981-988.
6. Komuro A, Bamming D, Horvath CM, (2008) Negative regulation of cytoplasmic RNA-mediated antiviral signaling. Cytokine 43: 350-358.
7. Liang Y, Ishida H, Lenz O, Lin TI, Nyanguile O, et al. (2008) Antiviral suppression vs restoration of RIG-I signaling by hepatitis C protease and polymerase inhibitors. Gastroenterology 135: 1710-1718 e1712.
8. Kim H, Seed B, (2010) The transcription factor MafB antagonizes antiviral responses by blocking recruitment of coactivators to the transcription factor IRF3. Nat Immunol 11: 743-750.
9. Cronin SJ, Nehme NT, Limmer S, Liegeois S, Pospisilik JA, et al. (2009) Genome-wide RNAi screen identifies genes involved in intestinal pathogenic bacterial infection. Science 325: 340-343.
10. Valanne S, Myllymaki H, Kallio J, Schmid MR, Kleino A, et al. (2010) Genome-wide RNA interference in Drosophila cells identifies G protein-coupled receptor kinase 2 as a conserved regulator of NF-kappaB signaling. J Immunol 184: 6188-6198.
11. Moore CB, Bergstralh DT, Duncan JA, Lei Y, Morrison TE, et al. (2008) NLRX1 is a regulator of mitochondrial antiviral immunity. Nature 451: 573-577.
12. Zhang XD, (2007) A new method with flexible and balanced control of false negatives and false positives for hit selection in RNA interference high-throughput screening assays. J Biomol Screen 12: 645-655.
13. Hutten S, Kehlenbach RH, (2007) CRM1-mediated nuclear export: to the pore and beyond. Trends Cell Biol 17: 193-201.
14. Kimura T, Hashimoto I, Nagase T, Fujisawa J, (2004) CRM1-dependent, but not ARE-mediated, nuclear export of IFN-alpha1 mRNA. J Cell Sci 117: 2259-2270.
15. Cullen BR, (2003) Nuclear mRNA export: insights from virology. Trends Biochem Sci 28: 419-424.
16. Yedavalli VS, Neuveut C, Chi YH, Kleiman L, Jeang KT, (2004) Requirement of DDX3 DEAD box RNA helicase for HIV-1 Rev-RRE export function. Cell 119: 381-392.
17. Schroder M, Baran M, Bowie AG, (2008) Viral targeting of DEAD box protein 3 reveals its role in TBK1/IKKepsilon-mediated IRF activation. EMBO J 27: 2147-2157.
18. Soulat D, Burckstummer T, Westermayer S, Goncalves A, Bauch A, et al. (2008) The DEAD-box helicase DDX3X is a critical component of the TANK-binding kinase 1-dependent innate immune response. EMBO J 27: 2135-2146.
19. Brass AL, Dykxhoorn DM, Benita Y, Yan N, Engelman A, et al. (2008) Identification of Host Proteins Required for HIV Infection Through a Functional Genomic Screen. Science 319: 921-926.
20. Konig R, Zhou Y, Elleder D, Diamond TL, Bonamy GM, et al. (2008) Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell 135: 49-60.
21. Zhou H, Xu M, Huang Q, Gates AT, Zhang XD, et al. (2008) Genome-scale RNAi screen for host factors required for HIV replication. Cell Host Microbe 4: 495-504.
22. Li Q, Brass AL, Ng A, Hu Z, Xavier RJ, et al. (2009) A genome-wide genetic screen for host factors required for hepatitis C virus propagation. Proc Natl Acad Sci U S A 106: 16410-16415.
23. Randall G, Panis M, Cooper JD, Tellinghuisen TL, Sukhodolets KE, et al. (2007) Cellular cofactors affecting hepatitis C virus infection and replication. Proc Natl Acad Sci U S A 104: 12884-12889.
24. Karlas A, Machuy N, Shin Y, Pleissner KP, Artarini A, et al. (2010) Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication. Nature 463: 818-822.
25. Konig R, Stertz S, Zhou Y, Inoue A, Hoffmann HH, et al. (2010) Human host factors required for influenza virus replication. Nature 463: 813-817.
26. Shapira SD, Gat-Viks I, Shum BO, Dricot A, de Grace MM, et al. (2009) A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection. Cell 139: 1255-1267.
27. Krishnan MN, Ng A, Sukumaran B, Gilfoy FD, Uchil PD, et al. (2008) RNA interference screen for human genes associated with West Nile virus infection. Nature 455: 242-245.
28. Yeretssian G, Correa RG, Doiron K, Fitzgerald P, Dillon CP, et al. (2011) Non-apoptotic role of BID in inflammation and innate immunity. Nature 474: 96-99.
29. Ting JP, Duncan JA, Lei Y, (2010) How the noninflammasome NLRs function in the innate immune system. Science 327: 286-290.
30. Mgbemena V, Segovia JA, Chang TH, Tsai SY, Cole GT, et al. (2012) Transactivation of inducible nitric oxide synthase gene by Kruppel-like factor 6 regulates apoptosis during influenza A virus infection. J Immunol 189: 606-615.
31. Chuang SS, Helvig C, Taimi M, Ramshaw HA, Collop AH, et al. (2004) CYP2U1, a novel human thymus- and brain-specific cytochrome P450, catalyzes omega- and (omega-1)-hydroxylation of fatty acids. J Biol Chem 279: 6305-6314.
32. Logan CY, Nusse R, (2004) The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20: 781-810.
33. Semenov MV, Habas R, Macdonald BT, He X, (2007) SnapShot: Noncanonical Wnt Signaling Pathways. Cell 131: 1378.
34. Gordon MD, Dionne MS, Schneider DS, Nusse R, (2005) WntD is a feedback inhibitor of Dorsal/NF-kappaB in Drosophila development and immunity. Nature 437: 746-749.
35. Liu X, Lu R, Wu S, Zhang YG, Xia Y, et al. (2011) Wnt2 inhibits enteric bacterial-induced inflammation in intestinal epithelial cells. Inflamm Bowel Dis 18: 418-29.
36. Liu X, Wu S, Xia Y, Li XE, Zhou ZD, et al. (2011) Wingless homolog Wnt11 suppresses bacterial invasion and inflammation in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 301: G992-G1003.
37. Banziger C, Soldini D, Schutt C, Zipperlen P, Hausmann G, et al. (2006) Wntless, a conserved membrane protein dedicated to the secretion of Wnt proteins from signaling cells. Cell 125: 509-522.
38. Bartscherer K, Pelte N, Ingelfinger D, Boutros M, (2006) Secretion of Wnt ligands requires Evi, a conserved transmembrane protein. Cell 125: 523-533.
39. Goodman RM, Thombre S, Firtina Z, Gray D, Betts D, et al. (2006) Sprinter: a novel transmembrane protein required for Wg secretion and signaling. Development 133: 4901-4911.
40. Veeman MT, Slusarski DC, Kaykas A, Louie SH, Moon RT, (2003) Zebrafish prickle, a modulator of noncanonical Wnt/Fz signaling, regulates gastrulation movements. Curr Biol 13: 680-685.
41. Yang P, An H, Liu X, Wen M, Zheng Y, et al. (2010) The cytosolic nucleic acid sensor LRRFIP1 mediates the production of type I interferon via a beta-catenin-dependent pathway. Nat Immunol 11: 487-494.
42. Trosset JY, Dalvit C, Knapp S, Fasolini M, Veronesi M, et al. (2006) Inhibition of protein-protein interactions: the discovery of druglike beta-catenin inhibitors by combining virtual and biophysical screening. Proteins 64: 60-67.
43. Chatel-Chaix L, Melancon P, Racine ME, Baril M, Lamarre D, (2011) Y-box-binding protein 1 interacts with hepatitis C virus NS3/4A and influences the equilibrium between viral RNA replication and infectious particle production. J Virol 85: 11022-11037.
44. Kubo F, Takeichi M, Nakagawa S, (2003) Wnt2b controls retinal cell differentiation at the ciliary marginal zone. Development 130: 587-598.
45. Beurel E, Michalek SM, Jope RS, (2010) Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3). Trends Immunol 31: 24-31.
46. Bose SK, Meyer K, Di Bisceglie AM, Ray RB, Ray R, (2012) Hepatitis C Virus Induces Epithelial Mesenchymal Transition in Primary Human Hepatocytes. J Virol 86: 13621-8.
47. Lei CQ, Zhong B, Zhang Y, Zhang J, Wang S, et al. (2010) Glycogen synthase kinase 3beta regulates IRF3 transcription factor-mediated antiviral response via activation of the kinase TBK1. Immunity 33: 878-889.
48. Martin M, Rehani K, Jope RS, Michalek SM, (2005) Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat Immunol 6: 777-784.
49. Gao HK, Yin Z, Zhou N, Feng XY, Gao F, et al. (2008) Glycogen synthase kinase 3 inhibition protects the heart from acute ischemia-reperfusion injury via inhibition of inflammation and apoptosis. J Cardiovasc Pharmacol 52: 286-292.
50. Gurrieri C, Piazza F, Gnoato M, Montini B, Biasutto L, et al. (2010) 3-(2,4-dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione (SB216763), a glycogen synthase kinase-3 inhibitor, displays therapeutic properties in a mouse model of pulmonary inflammation and fibrosis. J Pharmacol Exp Ther 332: 785-794.
51. Sanchez JF, Sniderhan LF, Williamson AL, Fan S, Chakraborty-Sett S, et al. (2003) Glycogen synthase kinase 3beta-mediated apoptosis of primary cortical astrocytes involves inhibition of nuclear factor kappaB signaling. Mol Cell Biol 23: 4649-4662.
52. Takada Y, Fang X, Jamaluddin MS, Boyd DD, Aggarwal BB, (2004) Genetic deletion of glycogen synthase kinase-3beta abrogates activation of IkappaBalpha kinase, JNK, Akt, and p44/p42 MAPK but potentiates apoptosis induced by tumor necrosis factor. J Biol Chem 279: 39541-39554.
53. Yuskaitis CJ, Jope RS, (2009) Glycogen synthase kinase-3 regulates microglial migration, inflammation, and inflammation-induced neurotoxicity. Cell Signal 21: 264-273.
54. Deng J, Xia W, Miller SA, Wen Y, Wang HY, et al. (2004) Crossregulation of NF-kappaB by the APC/GSK-3beta/beta-catenin pathway. Mol Carcinog 39: 139-146.
55. Die L, Yan P, Jun Jiang Z, Min Hua T, Cai W, et al. (2012) Glycogen synthase kinase-3 beta inhibitor suppresses Porphyromonas gingivalis lipopolysaccharide-induced CD40 expression by inhibiting nuclear factor-kappa B activation in mouse osteoblasts. Mol Immunol 52: 38-49.
56. Duan Y, Liao AP, Kuppireddi S, Ye Z, Ciancio MJ, et al. (2007) beta-Catenin activity negatively regulates bacteria-induced inflammation. Lab Invest 87: 613-624.
57. Ke B, Shen XD, Kamo N, Ji H, Yue S, et al. (2012) beta-Catenin regulates innate and adaptive immunity in mouse liver ischemia-reperfusion injury. Hepatology 57: 1203-14.
58. Gantner BN, Jin H, Qian F, Hay N, He B, et al. (2012) The Akt1 isoform is required for optimal IFN-beta transcription through direct phosphorylation of beta-catenin. J Immunol 189: 3104-3111.
59. Zhu J, Coyne CB, Sarkar SN, (2011) PKC alpha regulates Sendai virus-mediated interferon induction through HDAC6 and beta-catenin. EMBO J 30: 4838-4849.
60. Suriano AR, Sanford AN, Kim N, Oh M, Kennedy S, et al. (2005) GCF2/LRRFIP1 represses tumor necrosis factor alpha expression. Mol Cell Biol 25: 9073-9081.
61. Cruciat CM, Dolde C, de Groot RE, Ohkawara B, Reinhard C, et al. (2013) RNA helicase DDX3 is a regulatory subunit of casein kinase 1 in Wnt-beta-catenin signaling. Science 339: 1436-1441.
62. Neumann J, Schaale K, Farhat K, Endermann T, Ulmer AJ, et al. (2010) Frizzled1 is a marker of inflammatory macrophages, and its ligand Wnt3a is involved in reprogramming Mycobacterium tuberculosis-infected macrophages. FASEB J 24: 4599-4612.
63. Barton GM, Kagan JC, (2009) A cell biological view of Toll-like receptor function: regulation through compartmentalization. Nat Rev Immunol 9: 535-542.
64. Takada R, Satomi Y, Kurata T, Ueno N, Norioka S, et al. (2006) Monounsaturated fatty acid modification of Wnt protein: its role in Wnt secretion. Dev Cell 11: 791-801.
65. Willert K, Brown JD, Danenberg E, Duncan AW, Weissman IL, et al. (2003) Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature 423: 448-452.
66. Raymond VA, Selliah S, Ethier C, Houle R, Jouan L, et al. (2009) Primary cultures of human hepatocytes isolated from hepatitis C virus-infected cirrhotic livers as a model to study hepatitis C infection. Liver Int 29: 942-949.
67. Baril M, Racine ME, Penin F, Lamarre D, (2009) MAVS dimer is a crucial signaling component of innate immunity and the target of hepatitis C virus NS3/4A protease. J Virol 83: 1299-1311.
68. Berube P, Barbeau B, Cantin R, Sekaly RP, Tremblay M, (1996) Repression of human immunodeficiency virus type 1 long terminal repeat-driven gene expression by binding of the virus to its primary cellular receptor, the CD4 molecule. J Virol 70: 4009-4016.
69. Lin R, Mamane Y, Hiscott J, (2000) Multiple regulatory domains control IRF-7 activity in response to virus infection. J Biol Chem 275: 34320-34327.
70. Sharma S, tenOever BR, Grandvaux N, Zhou GP, Lin R, et al. (2003) Triggering the interferon antiviral response through an IKK-related pathway. Science 300: 1148-1151.
71. Kato T, Matsumura T, Heller T, Saito S, Sapp RK, et al. (2007) Production of infectious hepatitis C virus of various genotypes in cell cultures. J Virol 81: 4405-4411.
72. Jones CT, Murray CL, Eastman DK, Tassello J, Rice CM, (2007) Hepatitis C virus p7 and NS2 proteins are essential for production of infectious virus. J Virol 81: 8374-8383.
73. Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, et al. (1998) A third-generation lentivirus vector with a conditional packaging system. J Virol 72: 8463-8471.
74. Keskinen P, Nyqvist M, Sareneva T, Pirhonen J, Melen K, et al. (1999) Impaired antiviral response in human hepatoma cells. Virology 263: 364-375.
75. Schoggins JW, Wilson SJ, Panis M, Murphy MY, Jones CT, et al. (2011) A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472: 481-485.